Xiamen Amoytop Biotech Co., Ltd. Class ASSE: 688278

XIAMEN AMOYTOP BIOTECH CO., LTD. Announcement on Obtaining Notice of Approval for Drug Clinical Trial of ACT100 for Injection

· Issued by Xiamen Amoytop Biotech Co., Ltd. Class A via Shanghai Stock Exchange
XIAMEN AMOYTOP BIOTECH CO., LTD. Announcement on Obtaining Notice of Approval for Drug Clinical Trial of ACT100 for Injection

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis